Current Issue 2018  Archive 2017 
Biography
Biography

Editor-in-Chief of OBM Hepatology and Gastroenterology

Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.

Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.

Biography

The Associate Editor of OBM Hepatology and Gastroenterology

Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.

Special Issue

Liver Tumors and Liver Transplantation

Submission Deadline: February 25, 2019(Open)               Submit Now

Guest Editor

Chirag S. Desai, MD
Associate Professor of Surgery, Surgical Director, Liver Transplant Program, Director, Chronic Pancreatitis and Autologous Islet Cell Transplant Program, Department of Surgery, University of North Carolina, Chapel Hill, 4024 Burnett Womack Building, Chapel Hill, NC 27599, USA
E-Mail: [email protected]
Website: http://www.med.unc.edu/surgery/transplant/faculty/chirag-desai-md
Research Interests: Liver transplantation; intestinal and multivisceral transplantation; liver and pancreatobiliary disorders; chronic pancreatitis; autologous islet cell transplantation

About This Topic

Indications for liver transplantation in adult and pediatric populations are increasing with improving outcomes. Due to increased awareness, improving diagnostic modalities and screening protocols hepatocellular carcinomas are identified early on in patients with chronic liver disease and increasing number of patients are listed and transplanted. Patients with hepatobalstoma, cholangiocarcioma and other malignancies in the setting of metabolic liver disease are more frequently transplanted then previously and the allocation system continues to evolve.
In this special issue on liver tumors and liver transplantation, submissions are invited related to this topic. Original research, quality and quantitative systematic analysis, review article, case reports pertaining to all liver tumors benign or malignant, in the adult or pediatric populations are welcome for submission. Topics involving allocation, waiting list management, pre-transplant down staging, tumor control therapies, surgical technique, molecular biology and pathology, outcomes and post-transplantation management are all eligible.